Western blot analysis of Cortactin (pY421) expression in HeLa UV-treated (A); NIH3T3 H2O2-treated (B) whole cell lysates.
CTTN / Cortactin Antibody (phospho-Tyr421)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Immunohistochemistry, Paraffin, Western Blot |
| Reactivity: | Human, Mouse |
| Format: | Liquid |
$269.00each
Catalog Number: LS-C353975-30
Catalog Number: LS-C353975
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- Cortactin antibody LS-C353975 is an unconjugated rabbit polyclonal antibody to Cortactin (CTTN) (pTyr421) from human. It is reactive with human and mouse. Validated for IHC and WB. Cited in 1 publication.
- Application
- IHC-P, WB
- Reactivity
- Hu, Ms
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- Cortactin | CTTN | EMS1 | Oncogene EMS1 | Amplaxin | Src substrate cortactin
- Recommended Dilution: IHC-P
- 1:100 - 1:200
- Recommended Dilution: WB
- 1:500 - 1:1000
- UniProt Number
- Q14247
- NCBI GenBank
- NM_005231 | NP_005222.2
- SwissProt
- Q14247
Target
- Target
- Human CTTN / Cortactin
- Antigen Species
- Human
- Epitope
- Recognizes endogenous levels of Cortactin (pY421) protein.
- Gene Name
- CTTN
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
Immunogen
- Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the central region of human Cortactin (pY421).
- Immunogen Type
- Synthetic Peptide (Linear)
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, pH 7.3, 0.01% Sodium Azide, 30% Glycerol
- Volume
- 30 Microliter
- Preservative
- Yes
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Store at -20°C. Aliquot to avoid freeze/thaw cycles.
- Recommended Storage Buffer
- PBS
The Pathogenic Effect of Cortactin Tyrosine Phosphorylation in Cutaneous Squamous Cell Carcinoma. Zhu L#, Cho E#, Zhao G, Roh MR, Zheng Z. In Vivo. 2019 March-Apri;33:393-400. PubMed: 30804117 PMC: PMC6506328